Datatrak International, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 10, 2020 at 11:45 am EST
Share
DATATRAK International, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 1.752 million compared to USD 2.028 million a year ago. Operating loss was USD 28,243 compared to operating Income of USD 78,640 a year ago. Net loss was USD 26,724 compared to net income of USD 81,927 a year ago. For the nine months, sales was USD 5.448 million compared to USD 5.833 million a year ago. Operating loss was USD 4,947 compared to operating Income of USD 271,700 a year ago. Net loss was USD 1,856 compared to net income of USD 278,669 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
